Hemostasis Diagnostics Market Size, Share, Growth Report 2030

Hemostasis Diagnostics Market

Hemostasis Diagnostics Market by Product Type (Laboratory Systems, Consumables, and Point-of-Care Testing Systems), by Test Type (Prothrombin Test Time (PT), Activated Partial Thromboplastin Time (APTT), Fibrinogen Degradation Products (FDP), Activated Clotting Time, Platelet Aggregation Test, and D Dimer), and by End-User (Hospital & Clinics, Independent Diagnostic Laboratories, and Home Care Settings): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017—2024

Category: Healthcare Report Format : PDF Pages: 110 Report Code: ZMR-3726 Published Date: Jan-2019 Status : Published

Global hemostasis diagnostics market expected to generate revenue of around USD 7.3 billion by 2024, at a CAGR of around 8.1% between 2018 and 2024. Hemostasis is a process of slowing down or stopping bleeding from damaged blood vessels during this process the blood changes from liquid to a gelatinous state.

The report covers a forecast and an analysis of the Hemostasis Diagnostics Market on a global and regional level. The study provides historical data for 2015, 2016, and 2017 along with a forecast from 2018 to 2024 based on revenue (USD Billion). The study includes drivers and restraints of the Hemostasis Diagnostics Market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the Hemostasis Diagnostics Market on a global level.

In order to give the users of this report a comprehensive view of the Hemostasis Diagnostics Market, we have included a competitive landscape and an analysis of Porter’s Five Forces model of the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

Global Hemostasis Diagnostics MarketRequest Free Sample

The report provides company market share analysis to give a broader overview of the key market players. In addition, the report also covers key strategic developments in the market, including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved on the market on a global and regional basis.

The study provides a decisive view of the hemostasis diagnostics market by segmenting the market based on product type, test type, end-user, and region. All the segments have been analyzed based on present and future trends and the market are estimated from 2018 to 2024. 

By product type, the hemostasis diagnostics market is segmented into laboratory systems, consumables, and point-of-care testing systems. By test type, the hemostasis diagnostics market is segmented into prothrombin test time (PT), activated partial thromboplastin time (APTT), fibrinogen degradation products (FDP), activated clotting time, platelet aggregation test, and D dimer. By end-user, the hemostasis diagnostics Market is segmented into hospital and clinics, independent diagnostic laboratories, and home care settings.

The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further segmentation into major countries, such as the U.S., Germany, France, UK, China, Japan, India, and Brazil.

The major players of the global hemostasis diagnostics market include Siemens Healthineers, Abbott Laboratories, Instrumentation Laboratory, Thermo Fisher Scientific Inc., Alere Inc., Nihon Kohden Corporation, Sysmex Corporation, Danaher Corporation, F. Hoffmann-La Roche Ltd., and Grifols S.A. 

This report segments the global hemostasis diagnostics market into:

Global Hemostasis Diagnostics Market: Product Type Analysis

  • Laboratory Systems
  • Consumables
  • Point-of-Care Testing Systems

Global Hemostasis Diagnostics Market: Test Type Analysis

  • Prothrombin Test Time (PT)
  • Activated Partial Thromboplastin Time (APTT)
  • Fibrinogen Degradation Products (FDP)
  • Activated Clotting Time
  • Platelet Aggregation Test
  • D Dimer

Global Hemostasis Diagnostics Market: End-User Analysis

  • Hospital and Clinics
  • Independent Diagnostic Laboratories
  • Home Care Settings

Global Hemostasis Diagnostics Market: Regional Analysis

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

Methodology

Free Analysis

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed